Ganoderic acid Me inhibits tumor invasion through down-regulating matrix metalloproteinases 2/9 gene expression

Journal of Pharmacological Sciences

Volumn 108, Issue 2, 2008, Pages 212-216

  Chen, Nian Hong ^a   Liu, Jian Wen ^a   Zhong, Jian Jiang ^b  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Shanghai Jiao Tong University   (China)

Author keywords

Ganoderic acid Me (GA Me); Invasion; Matrix metalloproteinases 2 9 (MMP2 9)

Indexed keywords

GANODERIC ACID METHYL ESTER; GANODERMA LUCIDUM EXTRACT; GELATINASE A; GELATINASE B; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL AGGREGATION; DRUG EFFECT; DRUG MECHANISM; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; METASTASIS; METASTASIS INHIBITION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WOUND HEALING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL ADHESION; CELL AGGREGATION; CELL LINE, TUMOR; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; PROTEASE INHIBITORS; RNA, MESSENGER; TIME FACTORS; TRITERPENES;

EID: 55549103741     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.SC0080019     Document Type: Article

References (15)

1. Tang W, Gu TY, Zhong JJ. Separation of targeted ganoderic acids from Ganoderma lucidum by reversed phase liquid chromatography with ultraviolet and mass spectrometry detections. Biochem Eng J. 2006;32:205-210.
2. Russell R, Paterson M. Ganoderma - a therapeutic fungal biofactory. Phytochemistry. 2006;67:1985-2001.
3. Hu HB, Ahn NS, Yang XL, Lee YS, Kang KS. Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. Intl J Cancer. 2002;102:250-253.
4. Lu HM, Kyo E, Uesaka T, Katoh O, Watanabe H. A water-soluble extract from cultured medium of Ganoderma lucidum (Rei-shi) mycelia suppresses azoxymethane-induction of colon cancers in male F344 rats. Oncol Rep. 2003;10:375-379.
5. Kimura Y, Taniguchi M, Baba K. Antitumor and antimetastatic effects on liver of triterpenoid fractions of Ganoderma lucidum: mechanism of action and isolation of an active substance. Anticancer Res. 2002;22:3309-3318.
6. Lu QY, Jin YS, Zhang Q, Zhang Z, Heber D, Go VL, et al. Ganoderma lucidum extracts inhibit growth and induce actin polymerization in bladder cancer cells in vitro. Cancer Lett. 2004;216:9-20.
7. Wu QP, Xie YZ, Li SZ, La Pierre DP, Deng Z, Chen Q, et al. Tumor cell adhesion and integrin expression affected by Ganoderma lucidum. Enzyme Microb Tech. 2006;40:32-4126.
8. Thyagarajan A, Jiang J, Hopf A, Adamec J, Sliva D. Inhibition of oxidative stress-induced invasiveness of cancer cells by Ganoderma lucidum is mediated through the suppression of interleukin-8 secretion. Intl J Mol Med. 2006;18:657-664.
9. Sliva D, Labarrere C, Slivova V, Sedlak M, Lloyd FP Jr, Ho NW. Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells. Biochem Biophys Res Commun. 2002;298:603-612.
10. Wang G, Zhao J, Liu JW, Huang YP, Zhong JJ, Tang W. Enhancement of IL-2 and IFN-gamma expression and NK cells activity involved in the anti-tumor effect of ganoderic acid Me in vivo. Int Immunopharmacol. 2007;7:864-870.
11. Zhang J, Shen YL, Liu JW, Wei DZ. Antimetastatic effect of prodigiosin through inhibition of tumor invasion. Biochem Pharmacol. 2005;69:407-414.
12. Rao JY, Hemstreet GP, Hurst RE, Bonner RB, Jones PL, Min KW, et al. Alterations in phenotypic biochemical markers in bladder epithelium during tumorigenesis, Proc Natl Acad Sci U S A. 1993;90:8287-8291.
13. Chen HW, Yu SL, Chen JJ, Li HN, Lin YC, Yao PL, et al. Antiinvasive gene expression profile of curcumin in lung adenocarcinoma based on a high throughput microarray analysis. Mol Pharmacol. 2004;65:99-110.
14. Elkin M, Reich R, Nagler A, Aingorn E, Pines M, Hochberg A, et al. Inhibition of matrix metalloproteinase-2 expression and bladder carcinoma metastasis by halofuginone. Clin Cancer Res. 1999;5:1982-1988.
15. Hidalgo M, Eckhardt SG. Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst. 2001;93:178-193.